Kamoto T - Search Results

1

Identification of the α2 chain of interleukin-13 receptor as a potential biomarker for predicting castration resistance of prostate cancer using patient-derived xenograft models.

Nagai T, Terada N, Fujii M, Nagata Y, Nakahara K, Mukai S, Okasho K, Kamiyama Y, Akamatsu S, Kobayashi T, Iida K, Denawa M, Hagiwara M, Inoue T, Ogawa O, Kamoto T. Nagai T, et al. Among authors: kamoto t. Cancer Rep (Hoboken). 2023 Feb;6(2):e1701. doi: 10.1002/cnr2.1701. Epub 2022 Aug 9. Cancer Rep (Hoboken). 2023. PMID: 36806727 Free PMC article.

2

Clinical significance of nonpalpable prostate cancer with favorable biopsy features in Japanese men.

Kakehi Y, Kamoto T, Ogawa O, Kato T, Tobisu K, Akakura K, Egawa S, Usami M, Maeda O, Arai Y, Sumiyoshi Y, Kamiryo Y, Yoshida O. Kakehi Y, et al. Among authors: kamoto t. Eur Urol. 2000 May;37(5):552-8. doi: 10.1159/000020192. Eur Urol. 2000. PMID: 10765093

3

Per-operative frozen section examination of pelvic nodes is unnecessary for the majority of clinically localized prostate cancers in the prostate-specific antigen era.

Kakehi Y, Kamoto T, Okuno H, Terai A, Terachi T, Ogawa O. Kakehi Y, et al. Among authors: kamoto t. Int J Urol. 2000 Aug;7(8):281-6. doi: 10.1046/j.1442-2042.2000.00191.x. Int J Urol. 2000. PMID: 10976815 Free article.

4

[The advancement of diagnostic modalities for prostate cancer].

Kamoto T, Ogawa O. Kamoto T, et al. Nihon Rinsho. 2000 Jul;58 Suppl:75-8. Nihon Rinsho. 2000. PMID: 11022688 Review. Japanese. No abstract available.

5

Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.

Habuchi T, Liqing Z, Suzuki T, Sasaki R, Tsuchiya N, Tachiki H, Shimoda N, Satoh S, Sato K, Kakehi Y, Kamoto T, Ogawa O, Kato T. Habuchi T, et al. Among authors: kamoto t. Cancer Res. 2000 Oct 15;60(20):5710-3. Cancer Res. 2000. PMID: 11059764

6

Rapid detection of candidate metastatic foci in the orthotopic inoculation model of androgen-sensitive prostate cancer cells introduced with green fluorescent protein.

Maeda H, Segawa T, Kamoto T, Yoshida H, Kakizuka A, Ogawa O, Kakehi Y. Maeda H, et al. Among authors: kamoto t. Prostate. 2000 Dec 1;45(4):335-40. doi: 10.1002/1097-0045(20001201)45:4<335::aid-pros8>3.0.co;2-o. Prostate. 2000. PMID: 11102959

7

[A case of malignant fibrous histiocytoma arising from the renal capsule].

Kanno T, Kamoto T, Terai A, Kakehi Y, Terachi T, Ogawa O. Kanno T, et al. Among authors: kamoto t. Hinyokika Kiyo. 2001 Feb;47(2):95-8. Hinyokika Kiyo. 2001. PMID: 11280893 Free article. Review. Japanese.

8

[Progression from adenocarcinoma to small cell carcinoma of the prostate during endocrinotherapy: a case report].

Maeno A, Kamoto T, Kitamura K, Kanno T, Okuno H, Terai A, Kakehi Y, Terachi T, Ogawa O, Matsushiro H. Maeno A, et al. Among authors: kamoto t. Hinyokika Kiyo. 2001 Aug;47(8):591-3. Hinyokika Kiyo. 2001. PMID: 11579603 Free article. Japanese.

9

[Molecular epidemiology and cancer prevention].

Kamoto T, Ogawa O, Habuchi T, Kato T. Kamoto T, et al. Hinyokika Kiyo. 2001 Nov;47(11):833-6. Hinyokika Kiyo. 2001. PMID: 11771181 Free article. Japanese.

10

No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer.

Wang L, Habuchi T, Takahashi T, Kamoto T, Zuo T, Mitsumori K, Tsuchiya N, Sato K, Ogawa O, Kato T. Wang L, et al. Among authors: kamoto t. Int J Cancer. 2002 Feb 20;97(6):787-90. doi: 10.1002/ijc.10129. Int J Cancer. 2002. PMID: 11857355

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters